Maria Veleva’s Post

Heads up that if you’re in the Seattle Area, Excedr is sponsoring an event at CoMotion at University of Washington on Feb 28th! David Baker, UW Professor and Director of the Institute for Protein Design, University of Washington & Jenny Cronin, principal, AI2 Incubator will be discussing the impact of AI on life sciences & healthcare startups. I’ll be in town, and so will Jon and Kevin. If you’re in the area and free that Wednesday night, we’d love to see you there! I’ll post a link w/ details in the comments. #biotechnology #lifesciences #ai

Heads up that if you’re in the Seattle Area, Excedr is sponsoring an event at CoMotion at University of Washington on Feb 28th! Jenny Cronin, principal, AI2 Incubator & David Baker, UW Professor and Director of the Institute for Protein Design, University of Washington, will be discussing the impact of AI on life sciences & healthcare startups. I’ll be in town, and so will Jon Chee and Tara Fowler. If you’re in the area and free that Wednesday night, we’d love to see you there! I’ll post a link w/ details in the comments. #biotechnology #lifesciences #ai

Pierre Socha, Amadeus Partner, puts the biotech public markets under the microscope in this European Life Sciences Review article🔬 Despite biotech IPO challenges, venture capital is fuelling innovation in AI and synthetic biology, with the latter poised to become a $30 billion industry by 2026. This surge is transforming healthcare delivery, making it more accessible outside conventional hospitals. We're proud to support these groundbreaking innovations, delivered by the pioneering founders we back 🤝 Read the article here⬇️ https://bit.ly/3z4HmRR #LifeSciences #HealthTech #VentureCapital

Pierre Socha, Amadeus Partner, puts the biotech public markets under the microscope in this European Life Sciences Review article🔬 Despite biotech IPO challenges, venture capital is fuelling innovation in AI and synthetic biology, with the latter poised to become a $30 billion industry by 2026. This surge is transforming healthcare delivery, making it more accessible outside conventional hospitals. We're proud to support these groundbreaking innovations, delivered by the pioneering founders we back 🤝 Read the article here⬇️ https://bit.ly/3z4HmRR #LifeSciences #HealthTech #VentureCapital

What's the key to building the future of healthcare? Curious how our DNA can tailor intervention? How is it the real foundation for Medicine 3.0 & Longevity? And… how can we create great companies and commercial outcomes? We’ve joined forces with our friends Garvan Institute of Medical Research and What The Health for a community event on "Unlocking the future of genomics in real-life" From the latest insights from personal DNA, to the interplay of genomics and AI; We'll cover what’s happening in genomics, how it's set to completely overhaul health and we know it, and what we need to get there. Ft. our panel of experts:  🧬 Associate Professor Jodie Ingles - Head of Clinical Genomics at the Garvan Institute of Medical Research 🧬 Alex Gough - CEO & Co-founder from Sequins, and UK Biotech Investor 🧬 Emily Casey - Principal at Side Stage Ventures 📅 Wed 21st Feb  ⏰ 5:30 pm - 8 pm 📍Garvan Institute of Medical Research, Sydney 🥂Drinks & Nibbles provided Spots are limited so make sure to register here to save your spot! https://lnkd.in/gc7zqf96 #startups #vc #genomics #biotech #health

Reminder! Next Wednesday the 28th, Jenny Cronin and David Baker are discussing the impact of AI on life sciences and healthcare startups at CoMotion at University of Washington. There's still time to reserve a spot. Excedr is sponsoring, so yes, there will be food, and Jon Chee, Tara Fowler, and myself will all be there. Would love to see you if you’re able to join us! Registration link w/ details in the comments. #biotechnology #lifesciences #ai

Starting a new clinical trial is one of the most exciting things I have the opportunity do at Ani Biome. Although it is somewhat like picking the favorite child, out of all the finished and ongoing trials we have, this one is my favorite: Nutrition-gut-brain-stress-resilience. Beautiful! OH MY GUT is truly a state-of-the-art scientific project and I cannot wait to coshape and apply the breakthroughs that will come out of it. Proud to work with this team. Will post more details soon! 🧠♾️🚀 #gutbrain #mentalhealth #longevity #biotech #ai #innovation #appliedscience #humantrials #realscience #startup

Pierre Socha, a Partner on our Early Stage team, sheds light on the transformative life sciences landscape in a recent article published by European Life Sciences Review.   Despite challenges tied to biotech IPOs, venture capital continues to fuel innovation, particularly in generative AI and synthetic biology, the latter of which is projected to grow to a $30 billion market by 2026. A big effect of this are great advancements in in care delivery, with technology reshaping how healthcare is accessed and delivered within and beyond traditional hospital settings.   In other words, exciting times lie ahead for the convergence of technology and life sciences, and Amadeus is thrilled to be at the forefront of supporting groundbreaking innovations in this space! You can find the article here: https://lnkd.in/edQ54Tp7   #LifeSciences #HealthTech #VentureCapital 🌟

Just kicked off a 7-part journey into the fusion of biology and AI. It's a deep dive into how biology is evolving from a field of discovery to one of precise engineering. Gone are the days of stumbling upon breakthroughs like penicillin. Now, we're talking about crafting drugs on computers, testing their efficacy and safety digitally, decreasing the rate of failure, and drastically reducing cost. In this episode, Vijay Pande, from a16z walks us through these changes - from healthcare innovation, to doctors teaming up with AI co-pilots, to what's what's happening with biotech startups. It's a peek into a future where medicine and tech blend in ways we've only started to imagine. 🧬🖥️ This isn't just about solving big problems; it's about tackling challenges that matter deeply, that can truly change the world. We're standing at the threshold of an era where the brightest minds in tech and entrepreneurship are turning their attention to biology. Welcome to what could be the defining age of biology in the 21st century. Vijay Pande, PhD | Andreessen Horowitz | Software Engineering Daily https://lnkd.in/dUwceTh4

What if you had a Nextflow expert as your bioinformatics intern? With Seqera’s recent acquisition of Tinybio, we’re working to bring GenAI to your Nextflow workflows, enabling you to start developing complex pipelines with just a few simple prompts. How will you deploy your intern? #Bioinformatics #Nextflow #GenAI #Seqera